Effects of Human Papillomavirus Diagnosis on Relationships of Patients With Head and Neck Cancer
NCT04666428 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2025-05-15
Summary
This trial studies the effects of human papillomavirus diagnosis on the relationships of patients with head and neck cancer. Determining the effects of human papillomavirus diagnosis on relationships may determine whether human papillomavirus-positive patients and their partners are more likely to experience decline in relationship intimacy after diagnosis than human papillomavirus-negative patients and their partners. This may help researchers provide valuable insight into the degree to which a diagnosis of human papillomavirus affects patient relationships over and above the effects of a cancer diagnosis and address the need for additional patient counseling or education following diagnosis.
Conditions
- Head and Neck Carcinoma
Sponsors & Collaborators
-
Thomas Jefferson University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-24
- Primary Completion
- 2023-01-03
- Completion
- 2023-01-03
Countries
- United States
Study Locations
More Related Trials
-
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
NCT06984861 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity
NCT01525927 ·Status: TERMINATED ·Phase: PHASE2
-
Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation
NCT01958515 ·Status: COMPLETED
-
De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas
NCT03396718 ·Status: RECRUITING ·Phase: NA
-
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
NCT05491512 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries
NCT04489212 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma: a Phase II Clinical Trial
NCT04929067 ·Status: UNKNOWN ·Phase: PHASE2
-
Human Papillomavirus and Oropharynx Carcinoma
NCT00918710 ·Status: UNKNOWN
-
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
NCT01221753 ·Status: TERMINATED ·Phase: PHASE2
-
Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy
NCT04920344 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Patients with Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention
NCT06821243 ·Status: RECRUITING
-
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
NCT02281955 ·Status: COMPLETED ·Phase: PHASE2
-
Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
NCT04900623 ·Status: RECRUITING ·Phase: PHASE2
-
The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study
NCT02126189 ·Status: UNKNOWN
-
Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer
NCT06997094 ·Status: RECRUITING ·Phase: PHASE1
-
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
NCT06223568 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Swallowing Exercises on Patients Undergoing Radiation Treatment for Head and Neck Cancer
NCT01053546 ·Status: TERMINATED ·Phase: NA
-
Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx Cancers
NCT02628912 ·Status: WITHDRAWN
-
Anti-tumor Specific Immune Response in Head and Neck Cancers
NCT02881918 ·Status: UNKNOWN
-
Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
NCT02048020 ·Status: COMPLETED ·Phase: PHASE2
-
De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
NCT03952585 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca
NCT01530997 ·Status: COMPLETED ·Phase: PHASE2
-
Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC
NCT06693323 ·Status: RECRUITING ·Phase: PHASE2
-
Studying Survivorship Care Plans in Head and Neck Cancer
NCT03106090 ·Status: TERMINATED ·Phase: NA
-
Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers
NCT05582590 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1